Delivery Order SPE2DR25D3103-SPE2DR26F9Q46
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,263.28 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages). This firm fixed price, competitively awarded contract was executed on October 23, 2025, with an ultimate completion date of October 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,311.49 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on December 17, 2025, with an ultimate completion date of December 18, 2025. This competitively awarded, firm fixed-price contract was issued with no set-aside designation and represents a continuation of the company's pharmaceutical supply services to federal medical systems. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,130.81 on July 31, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price, competitively awarded contract has an ultimate completion date of August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $24,482.11 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on December 11, 2025, with completion expected by December 12, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement supporting federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $17,796.50 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a $49,813.65 delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with an ultimate completion date of December 17, 2025. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle valued through...
- The Defense Logistics Agency awarded a delivery order valued at $2,961.21 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed price delivery order represents a competitively awarded, non-set-aside contract with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $14,265.11 on November 14, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of November 17, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $10,756.42 to AmerisourceBergen Drug Corp for the supply of Jardiance 10mg tablets (90-count) on November 18, 2025, with completion scheduled for December 16, 2025. This firm fixed-price, non-set-aside contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $1,658.26 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg on September 23, 2025, with completion scheduled for September 24, 2025. This is a firm fixed-price, non-set-aside contract for pharmaceutical delivery to support federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9Q46Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,649.61 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price, competitively awarded contract was issued on December 17, 2025, with an ultimate completion date of December 18, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp leverages its prime IDC to fulfill diverse medical supply requirements across military healthcare systems and other government agencies, including the Defense Health Agency and U.S. Coast Guard. The company's extensive contract portfolio demonstrates its capability to supply a comprehensive range of pharmaceutical products spanning multiple therapeutic domains, from specialty medications to vaccines and medical devices. This delivery order for Jardiance, a diabetes medication, represents a routine transaction within AmerisourceBergen's ongoing support of federal healthcare procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 12/16/25 |